FDA Authorizes 24 New Velo Nicotine Pouch Products
The newly approved 4mg nicotine pouches are intended for adults aged 21 and older as alternatives to combustible tobacco.
Updated on Oct. 30, 2026 in Substance Abuse
Live Poll
Should the government authorize more nicotine pouch products as alternatives to traditional cigarettes?
The FDA has granted market authorization for 24 new Velo-brand nicotine pouches, each containing 4 milligrams of nicotine. These products are intended for adults aged 21 and older as non-combusted alternatives to traditional tobacco.
Why it matters
The agency authorized these pouches to provide adults access to tobacco alternatives with lower levels of harmful constituents compared to cigarettes and smokeless tobacco. The move continues the FDA's regulatory oversight of the nicotine pouch market.
The FDA authorized these 24 products through the Premarket Tobacco Product Application (PMTA) pathway and a dedicated nicotine pouch pilot program. This brings the total number of authorized nicotine pouch products to 67, with each pouch in this latest group containing 4 milligrams of nicotine.
The players
FDA
The federal agency responsible for protecting public health by regulating the safety and efficacy of tobacco products, food, and pharmaceuticals.
Modoral Brands
The manufacturer responsible for producing the Velo line of nicotine pouches.
The details
The FDA reviewed these products to ensure they meet the standard of being appropriate for the protection of public health. The products, which include Velo Mini Pouch and Velo Mini Pouch 2 varieties, contain lower levels of harmful chemical constituents than combustible cigarettes or traditional smokeless tobacco. Additionally, all authorized packaging incorporates specific child-resistant features to mitigate accidental exposure risks.
Timeline
October 30, 2026: The FDA issued the official authorization for the 24 Velo nicotine pouch products.
Health Landscape
The FDA's authorization of these pouches reflects the current regulatory focus on evaluating non-combusted tobacco alternatives through the PMTA framework. This process aims to categorize products by their chemical profile relative to combustible tobacco as the industry evolves.
These products are specifically authorized for adults aged 21 and older, and the inclusion of child-resistant packaging is a key safety measure for households. If you are considering changes to your tobacco or nicotine use, it is a conversation worth having with your physician.
The takeaway
While these products contain lower levels of harmful constituents than combustible cigarettes, they still deliver nicotine, a highly addictive substance. Adults navigating nicotine use should prioritize discussions with a healthcare provider about evidence-based cessation strategies.
Further reading
For more on the regulatory environment for tobacco, visit Substance Abuse.
Live Poll
Should the government authorize more nicotine pouch products as alternatives to traditional cigarettes?
